Miracle Mile Advisors’s Cameco CCJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$882K Sell
8,660
-1,977
-19% -$222K 0.01% 474
2026
Q1
$1.16M Sell
10,637
-12
-0.1% -$1.37K 0.02% 394
2025
Q4
$974K Sell
10,649
-1,463
-12% -$132K 0.01% 423
2025
Q3
$1.02M Buy
12,112
+2,670
+28% +$207K 0.02% 413
2025
Q2
$701K Buy
9,442
+503
+6% +$26.8K 0.01% 422
2025
Q1
$368K Buy
8,939
+94
+1% +$4.42K 0.01% 486
2024
Q4
$455K Buy
8,845
+495
+6% +$27K 0.01% 452
2024
Q3
$399K Hold
8,350
0.01% 382
2024
Q2
$411K Buy
8,350
+350
+4% +$17.7K 0.01% 363
2024
Q1
$347K Hold
8,000
0.01% 386
2023
Q4
$345K Sell
8,000
-202
-2% -$8.45K 0.01% 374
2023
Q3
$325K Buy
8,202
+202
+3% +$7.15K 0.01% 391
2023
Q2
$251K Hold
8,000
0.01% 445
2023
Q1
$209K Buy
+8,000
New +$211K 0.01% 474
2022
Q4
Sell
-8,000
Closed -$212K 513
2022
Q3
$212K Buy
+8,000
New +$205K 0.01% 404
2022
Q2
Sell
-8,000
Closed -$233K 449
2022
Q1
$233K Buy
+8,000
New +$188K 0.01% 421

Other funds holding CCJ

Miracle Mile Advisors's CCJ Position: Q2 2026 in Review

Miracle Mile Advisors reduced its Cameco (CCJ) stake by 19% in Q2 2026, selling an estimated $222K and leaving 8,660 shares worth $882K. The position accounts for 0.01% of the portfolio, ranked #474.

Miracle Mile Advisors first reported a position in CCJ in Q1 2022 and has held it in 16 quarters since. The position peaked at $1.16M in Q1 2026. 1,036 funds tracked by Wall St. Rank hold CCJ as of Q2 2026.

  • Miracle Mile Advisors held 8,660 shares of Cameco worth $882K as of Q2 2026.
  • Miracle Mile Advisors sold 1,977 Cameco shares in Q2 2026, an estimated $222K.
  • Cameco made up 0.01% of Miracle Mile Advisors's portfolio in Q2 2026, its #474 holding.
  • Miracle Mile Advisors first reported a position in Cameco in Q1 2022 and has held it in 16 quarters since.
  • Miracle Mile Advisors's Cameco position peaked at $1.16M in Q1 2026.
  • 1,036 funds tracked by Wall St. Rank held Cameco as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.